← Open Payments lookup

RASHMI OJHA: Open Payments

NPI 1407056476 · COLUMBUS, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,021 in 44 payments from 11 companies in 2025. Trend: 2023 $957 · 2024 $728 · 2025 $1,021

Food & beverage: $898Education: $122
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.5$182
ABBVIE INC.14$181
Teva Pharmaceuticals USA, Inc.7$148
Otsuka America Pharmaceutical, Inc.6$147
Alkermes, Inc.6$129
Neurocrine BioSciences, Inc.1$120
HARMONY BIOSCIENCES LLC1$47
Lundbeck LLC1$22
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$16
Axsome Therapeutics, Inc.1$15

Products named: VRAYLAR, COBENFY, ABILIFY MAINTENA, INGREZZA, ARISTADA, LYBALVI, AUSTEDO XR, REXULTI.

Industry payments across NE — which companies pay providers there.